|Articles|December 1, 2014
- BioPharm International-12-01-2014
- Volume 27
- Issue 12
BioPharm International, December 2014 Issue (PDF)
Click the title above to open the BioPharm International December 2014 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 11 years ago
The Biopharma Working Lifealmost 11 years ago
FDA Realigns Drug Inspection and Manufacturing Oversightalmost 11 years ago
Year in Review: Key Outsourcing Trendsalmost 11 years ago
Improving PAT for Biologicsalmost 11 years ago
Job Security and Salaries Trend Upwardalmost 11 years ago
A Next Generation of Quality Managementalmost 11 years ago
Purification Resin Increases EfficiencyNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
What a $2 Billion Maryland Expansion Means for the Future of Biologics Production
2
How New ADC Modalities Backed by Samsung Could Shape Solid Tumor Treatment
3
Op-Ed: Why the US Must Move Beyond Its mRNA Monoculture
4
Industry Experts Probe CNPV Impacts: Part II
5
